CLINICAL_TRIALS
trial_result
· 2011-03-21
Clinical Trial Update: Protect II, A Prospective, Multicenter Randomized Controlled Trial [Phase 3]
Summary
A Phase 3 multicenter randomized trial named Protect II sponsored by Abiomed assessing treatment for coronary artery disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Abiomed Inc. | Conditions: Coronary Artery Disease | Phase 3 | Status: TERMINATED